Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex

Vertex Has a Pain Pill That May Replace Opioids

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

The Street

Dow Jones Falls As Biden Taps Emergency Oil, Inflation Gauge Hits 39-Year High; Pharma Leader Pops

The Dow Jones fell as President Joe Biden tapped the nation's emergency oil reserves. The Fed's favorite inflation gauge spiked.

Investors Business Daily

Dow Jones Continues To Pull Back After Recent Rally; Investors Await Biden's Release Of Oil Reserves

Elsewhere, Paychex rose over 1% and moved above a proper buy point.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Vertex Touts Positive Data From Mid-Stage Study Of Its Non-Opioid Pain Drug

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) released positive results from two Phase 2 post-operative trials for its non-opioid program, VX-548. One trial looked at patients who had just received a bunionectomy (Correcting the deformity of toes & foot), the other in patients who received abdominoplasty (tummy tuck). Vertex said that within 48 hours of surgery,…

Benzinga

Stock Market Falls As Biden To Release Oil Reserves; Key Inflation Rate Rises

The stock market traded lower as President Biden prepared to release oil reserves, sending oil prices lower.

Investors Business Daily

Vertex Continues Its Meteoric Run After Its Opioid Alternative Scores In A Key Test

Vertex announced promising test results for its opioid alternative on Thursday, sending VRTX stock deeper into breakout territory.

Investors Business Daily

Well played: Cause for celebration as cystic fibrosis drug added to the PBS

Without PBS subsidy, around 1,900 Australians would be up for more than $250,000 a year to access the CF drug.

Newcastle Herald

Read news from The Economist, FT, and more,
with one subscription

IBD Screen Of The Day: 3 Stocks Near Buy Points With Rising Profit Estimates

Vertex Pharmaceuticals has been outperforming and ranks second in the biotech industry group.

Investors Business Daily

Dow Jones Futures: Nasdaq Breaks Lower; China Covid Shutdowns Are New X Factor

China's Covid shutdowns slammed tech stocks and oil prices. The Nasdaq broke below its Feb. 24 lows, but the S&P 500 hasn't yet.

Investors Business Daily

What's Going On With Vertex Energy Shares Today?

Vertex Energy Inc (NASDAQ: VTNR) is trading higher on above-average volume Thursday as oil prices gain following the collapse of Russia-Ukraine ceasefire talks.

Benzinga

Vertex Pharma Has a Cystic Fibrosis Drug That Rivals Envy

A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.

The Street

Biotech Vertex Pharma Has a Blockbuster Drug That Rivals Envy

A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.

The Street

Vertex Clocks 12% Revenue Growth In Q4 Backed By ARR, NRR Momentum; Issues FY22 Guidance Above Consensus

Vertex Inc (NASDAQ:VERX) reported fourth-quarter FY21 revenue growth of 12.2% year-on-year to $111.7 million, beating the consensus of $109.2 million. Software subscription revenues rose 11.1% Y/Y to $93.3 million, and Cloud revenues increased 38.9% Y/Y to $34.7 million. Drivers: Annual Recurring Revenue rose 17% Y/Y to $370.2 million. The Average Annual Revenue per customer…

Benzinga

Vertex: Q4 Earnings Insights

Vertex (NASDAQ:VERX) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Vertex Energy Stock Skyrockets After Q4 Results; Expects To Close Mobile Refinery Deal As Planned

Vertex Energy Inc (NASDAQ:VTNR) reported fourth-quarter revenue growth of 82.5% year-over-year to $31.79 million, beating the consensus of $29.37 million. Q4 Adjusted net income recovered to $4.64 million from a loss of $(2.74) million in 4Q20. The gross margin declined by 130 bps to 1%. The company reported an operating loss of $(7.46)…

Benzinga

Vertex Earnings Preview

Vertex (NASDAQ:VERX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement. Analysts estimate that Vertex will report an earnings per share (EPS) of $0.05.

Benzinga

Vectrus Agrees To Merge With Vertex

Vectrus Inc (NYSE:VEC) entered a definitive agreement to combine with The Vertex Company in an all-stock merger. Vertex Company is headquartered in Madison, Mississippi, and employs ~6,000 employees. Vertex is majority-owned by American Industrial Partners Capital Fund VI LP. Vertex delivers integrated turnkey lifecycle support from concept definition to engineering and manufacturing.…

Investors Business Daily

Sector Wars: Tesla Stock Tumbles As Two Leaders Rise, One Gets Sold Into Strength

As Tesla, Nvidia and Microsoft struggle, CF Industries gets sold into strength and Union Pacific and Vertex try to buck the market correction.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

As Vertex Stock Looks More Bullish, This Trade Limits Risk

The ideal scenario for this Vertex stock option trade is a rise up to 260 around April 14 with stable or rising implied volatility.

Investors Business Daily

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.

Investors Business Daily

Dow Jones Futures Pare Losses, Crude Oil Jumps; Market Correction Nearing New Leg Down Amid Russia's Ukraine Invasion

Futures fell while crude oil prices skyrocketed on Russia oil embargo risks. The stock market rally is nearing February lows as Russia's Ukraine invasion continues.

Investors Business Daily

Why IBD Stock Of The Day Vertex Is Outperforming Its Biotech Brethren

Vertex stock is the IBD Stock Of The Day after bounding off its key moving averages as excitement grows for its non-cystic fibrosis plans.

Investors Business Daily

Three Shrewd Moves In A Bad Market By Top Fidelity Brains

In a bad market, what's one of the top Fidelity funds up to? Growth Discovery, one of the best mutual funds anywhere, is making three savvy moves.

Benzinga

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

Benzinga

Vertex Pharmaceuticals Clocks 27% Growth In Product Revenues, Issues FY22 Guidance

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) posted

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.